Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-08-19
2009-08-25
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007100
Reexamination Certificate
active
07579160
ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly lung cancer, are disclosed. Illustrative compositions comprise one or more lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung cancer.
REFERENCES:
patent: 5444149 (1995-08-01), Keene et al.
patent: 5589579 (1996-12-01), Torczynski et al.
patent: 5705159 (1998-01-01), Irie et al.
patent: 5783422 (1998-07-01), Suminami et al.
patent: 6200764 (2001-03-01), Carney
patent: 6255055 (2001-07-01), Ross
patent: 6297364 (2001-10-01), Chen et al.
patent: 2003/0236209 (2003-12-01), Foy et al.
patent: 679716 (1994-11-01), None
patent: 695760 (1996-02-01), None
patent: 1033401 (2000-09-01), None
patent: 1130094 (2001-09-01), None
patent: WO 91/18926 (1991-12-01), None
patent: WO 94/06929 (1994-03-01), None
patent: WO 95/21862 (1995-08-01), None
patent: WO 96/02552 (1996-02-01), None
patent: WO 96/28473 (1996-09-01), None
patent: WO 96/30389 (1996-10-01), None
patent: WO 97/07244 (1997-02-01), None
patent: WO 98/35985 (1998-08-01), None
patent: WO 98/46788 (1998-10-01), None
patent: WO 99/38973 (1999-08-01), None
patent: 99/44620 (1999-09-01), None
patent: WO 99/46594 (1999-09-01), None
patent: WO 99/47674 (1999-09-01), None
patent: WO 99/54738 (1999-10-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 01/47944 (2001-07-01), None
patent: WO 01/55322 (2001-08-01), None
patent: WO 01/57272 (2001-08-01), None
patent: WO 01/57275 (2001-08-01), None
patent: WO 01/57276 (2001-08-01), None
patent: WO 01/57277 (2001-08-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 01/94629 (2001-12-01), None
patent: WO 02/00174 (2002-01-01), None
patent: WO 02/20036 (2002-03-01), None
patent: WO 2004/018999 (2004-03-01), None
patent: WO 2004/091548 (2004-10-01), None
Zhang et al., Clinical Immunology vol. 100, p. 149-156, 2001.
Vijayalakshmi et al., Eur J Gynaecol Oncol, vol. 23 p. 135-138, 2002, abstract.
Pinion et al., Lancet, vol. 337, p. 819-820, 1991, abstract.
Kim et al., Mol and Cell Biol. vol. 23, p. 708-720, 2003.
Doyle and Ross, Nucleic acids Res vol. 26, p. 5036, 1998.
Ackermann, R. “Monoclonal antibodies,”Human Cell1(1): 46-53, 1988 (Abstract Only; PubMed ID:3154013).
Arceci, R.J, “The potential for antitumor vaccination in acute myelogenous leukemia,”J. Mol. Med.76: 80-93, 1998.
Baldi et al., “Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer,”Clinical Cancer Research3(10):1691-1697, Oct. 1997.
Bergers and Coussens, “Extrinsic regulators of epithelial tumor progression: metalloproteinases,”Current Opinion in Genetics & Developments10: 120-127, 200.
Bodey, B. et al., “Failure of Cancer Vaccines: the Significant Limitations of this Approach to Immunotherapy,”Anticancer Research20: 2665-2676, 2000.
Boon, T., “Toward a Genetic Analysis of Tumor Rejection Antigens,”Advances in Cancer Research58: 177-210, 1992.
Brass et al., “Translation initiation factor elF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma,”Human Molecular Genetics, 6(1): 33-39, 1997.
Chen, Shen-Lin et al., “Isolation and characterization of a novel gene expressed in multiple cancers,”Oncogene12: 741-751, 1996.
Chen, Y.-T. et al., “A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening”Proc. Natl. Acad. Sci.USA 94: 1914-1918, Mar. 1997.
Database EMBL Nucleotide and Protein Sequence, Accession No. A1468638, Mar. 17, 1999.
Database EMBLest17 Accession No. AA340797:EST46165 Fetal kidney II Homo sapiens cDNA 3' end, Apr. 18, 1997.
Database EMBLestl 7 Accession No. W22264:Human retina cDNATsp-509I-cleaved sublibrary Homo sapiens cDNA not directional, May 9, 1996.
Davidson et al., “Lung tumours immunoreactive for parathyroid hormone related peptide: of serum calcium levels and tumour type,”Journal of Pathology178:398-401, Jan. 1996.
Eck and Wilson, “Gene-Based Therapy,” inGoodman & Gilman's The Pharmacological Basis of Therapeutics, 9thEdition, McGraw-Hill, New York, 1996, pp. 77-101.
Ezzell, C., “Cancer ‘Vaccines’: An Idea Whose Time Has Come?”The Journal of NIH Research7: 46-49, Jan. 1995.
Finch et al., “Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin,”Carcinogenesis, 12(8):1519-1522, Aug. 1991.
GenBank Database, Accession No. AAB82295, Oct. 30, 1997.
GenBank Database, Accession No. AAB97457, Jan. 22, 1998.
GenBank Database, Accession No. AAC18597, Jun. 3, 1998.
GenBank Database, Accession No. AAC18598, Jun. 3, 1998.
GenBank Database, Accession No. AAC35208, May 13, 1997.
GenBank Database, Accession No. AAC41285, May 13, 1998.
GenBank Database, Accession No. AAD09223, Jan. 26, 1999.
GenBank Database, Accession No. AAD09827, Jan. 26, 1999.
GenBank Database, Accession No. AAD09828, Jan. 26, 1999.
GenBank Database, Accession No. AAF37203, Mar. 2, 2000.
GenBank Database, Accession No. AC005082, Sep. 8, 1999.
GenBank Database, Accession No. ACO21876, Jan. 21, 2000.
GenBank Database, Accession No. AC079780, Feb. 21, 2002.
GenBank Database, Accession No. AC092447, Jul. 4, 2001.
GenBank Database, Accession No. AF043977, Jun. 23, 1999.
GenBank Database, Accession No. AF117108, Jan. 26, 1999.
GenBank Database, Accession No. AF198254, Mar. 2, 2000.
GenBank Database, Accession No. AL023775, Nov. 23, 1999.
GenBank Database, Accession No. BAB19755, Dec. 20, 2000.
GenBank Database, Accession No. BAB27779, Feb. 8, 2001.
GenBank Database, Accession No. BAB27848, Feb. 8, 2001.
GenBank Database, Accession No. BC019258, Dec. 19, 2001.
GenBank Database, Accession No. NM—006547, Nov. 1, 2000.
GenBank Database, Accession No. NP—006537, Aug. 10, 1999.
GenBank Database, Accession No. NP—006538, Nov. 1, 2000.
GenBanIc Database, Accession No. NP—006539, Aug. 10, 1999.
GenBank Database, Accession No. NP—034081, Jan. 25, 2000.
GenBank Database, Accession No. NP—076159, Feb. 19, 2001.
GenBank Database, Accession No. NP—571566, Feb. 20, 2002.
GenBank Database, Accession No. O00425, Jul. 1, 1997.
GenBank Database, Accession No. U76705, Jan. 26, 1999.
GenBank Database, Accession No. U85946, Jul. 30, 1999.
GenBank Database, Accession No. U97188, May 20, 1997.
GenBank Database, Accession No. XM—004780, Nov. 16, 2000.
GenBank Database, Accession No. XP—004780, Nov. 16, 2000.
Geneseq Accession No. AAC66035, Feb. 21, 2001.
Geneseq Accession No. AAZ24653, Dec. 7, 1999.
Geneseq Accession No. AAZ36150, Dec. 7, 1999.
Geneseq Database (Thomson Derwent), Accession AAL28189, Jan. 24, 2002.
Geneseq Database (Thomson Derwent), Accession AAM93826, Nov. 6, 2001.
Geneseq Database (Thomson Derwent), Accession AAT26750, Oct. 23, 1996.
Geneseq Database (Thomson Derwent), Accession AAU16161, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16163, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16164, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16166, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16579, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16583, Nov. 7, 2001.
Gerhold and Caskey, “It's the genes! EST access to human genome content,”BioEssays18(12):973-981, 1996.
Greenspan and Cooper, “Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions,”Immunology Today16(5): 226-230, 1995.
Gruber et al., “Molecular cloning and transmembrane structure of hCLCA2 from human lung, trachea, and mammary gland,”Am. J. Physiol.276(Cell Physiol 45):C1261-C1270, 1999.
Guo et al., “Identif
Bangur Chaitanya S.
Zehentner-Wilkinson Barbara K.
Corixa Corporation
Helms Larry R.
SeedIP Law Group PLLC
Yao Lei
LandOfFree
Methods for the detection of cervical cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the detection of cervical cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the detection of cervical cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4127274